← Open Payments lookup

ANTHONY DUK: Open Payments

NPI 1154439131 · REDLANDS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,032 in 207 payments from 19 companies in 2025. Trend: 2023 $2,267 · 2024 $2,307 · 2025 $4,032

Food & beverage: $4,026Education: $5
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.31$599
ABBVIE INC.31$598
Teva Pharmaceuticals USA, Inc.27$521
Alkermes, Inc.22$472
E.R. Squibb & Sons, L.L.C.25$412
Neurocrine BioSciences, Inc.17$395
Janssen Pharmaceuticals, Inc18$293
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$180
Lundbeck LLC13$143
Almatica Pharma LLC7$140

Products named: VRAYLAR, REXULTI, ARISTADA, INGREZZA, AUSTEDO XR, COBENFY, INVEGA SUSTENNA, CAPLYTA.

Industry payments across CA — which companies pay providers there.